| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1099682344 |
| P356 | DOI | 10.1186/S12957-017-1287-0 |
| P932 | PMC publication ID | 5732439 |
| P698 | PubMed publication ID | 29246227 |
| P50 | author | David Renman | Q89653059 |
| P2093 | author name string | Erik Lundberg | |
| Ulf Gunnarsson | |||
| Karin Strigård | |||
| P2860 | cites work | Neither Long-Term Statin Use nor Atherosclerotic Disease Is Associated With Risk of Colorectal Cancer | Q57300385 |
| Long-Term Use of Statins and Risk of Colorectal Cancer: A Population-Based Study | Q58873374 | ||
| The Risk of Cancer in Users of Statins | Q63865877 | ||
| Statins and the risk of lung, breast, and colorectal cancer in the elderly | Q79441602 | ||
| [The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases] | Q80202595 | ||
| Obesity and colorectal cancer | Q86354720 | ||
| European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary | Q87378887 | ||
| Statins for the primary prevention of cardiovascular disease | Q24201513 | ||
| Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies | Q26864624 | ||
| Statins and the risk of colorectal cancer | Q28176056 | ||
| HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2 | Q28201997 | ||
| Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study | Q28209955 | ||
| Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study | Q28219205 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
| A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine | Q29547303 | ||
| Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | Q29617817 | ||
| 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres | Q34046881 | ||
| Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors | Q34432988 | ||
| Somatic mutations of the mitochondrial genome in human colorectal tumours | Q34478926 | ||
| Statins and cancer risk: a meta-analysis | Q34481478 | ||
| Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? | Q34632247 | ||
| Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q34656360 | ||
| Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database | Q35069176 | ||
| Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease | Q35978349 | ||
| Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update | Q36014966 | ||
| Spectrum of somatic mitochondrial mutations in five cancers | Q36212908 | ||
| Cardiovascular medication use and risk for colorectal cancer | Q37175363 | ||
| Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk | Q37244283 | ||
| Statin use and all-cause and cancer mortality: BioBank Japan cohort | Q37700224 | ||
| The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy | Q37703526 | ||
| Cardiovascular effects of statins, beyond lipid-lowering properties | Q38196178 | ||
| Cancer risk among statin users: a population-based cohort study | Q38476237 | ||
| Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells | Q39649573 | ||
| Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis | Q42153153 | ||
| Incidence of cancer and statin usage--record linkage study | Q43279302 | ||
| Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site | Q43625666 | ||
| Statins and colorectal cancer risk: a longitudinal study | Q43973857 | ||
| Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells | Q45261087 | ||
| The association between statins and cancer incidence in a veterans population | Q45332064 | ||
| Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways | Q46718388 | ||
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 222 | |
| P577 | publication date | 2017-12-16 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study | |
| P478 | volume | 15 |
Search more.